| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 19 | 2026 | 738 | 4.040 |
Why?
|
| Telemedicine | 13 | 2026 | 379 | 3.440 |
Why?
|
| Text Messaging | 7 | 2026 | 98 | 1.890 |
Why?
|
| Diabetes Mellitus | 10 | 2017 | 558 | 1.890 |
Why?
|
| Self Care | 13 | 2026 | 218 | 1.740 |
Why?
|
| Pharmacists | 7 | 2026 | 131 | 1.730 |
Why?
|
| Community Health Workers | 5 | 2026 | 41 | 1.450 |
Why?
|
| Patient Education as Topic | 7 | 2024 | 489 | 1.220 |
Why?
|
| Urban Population | 7 | 2026 | 201 | 1.210 |
Why?
|
| Feasibility Studies | 6 | 2024 | 593 | 1.140 |
Why?
|
| Health Education | 4 | 2017 | 191 | 1.020 |
Why?
|
| Middle Aged | 45 | 2026 | 18501 | 1.010 |
Why?
|
| Diabetes, Gestational | 2 | 2021 | 142 | 1.000 |
Why?
|
| Self-Management | 2 | 2026 | 72 | 1.000 |
Why?
|
| Hypoglycemic Agents | 4 | 2020 | 226 | 0.960 |
Why?
|
| Female | 61 | 2026 | 34425 | 0.920 |
Why?
|
| Obesity | 11 | 2025 | 1281 | 0.910 |
Why?
|
| Respiratory Tract Infections | 1 | 2026 | 90 | 0.900 |
Why?
|
| Humans | 87 | 2026 | 65845 | 0.890 |
Why?
|
| Home Care Services | 1 | 2026 | 105 | 0.890 |
Why?
|
| Adult | 36 | 2026 | 17579 | 0.860 |
Why?
|
| Weight Loss | 6 | 2021 | 276 | 0.820 |
Why?
|
| Prediabetic State | 3 | 2023 | 54 | 0.810 |
Why?
|
| Medication Adherence | 4 | 2020 | 202 | 0.790 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 67 | 0.760 |
Why?
|
| Aggression | 1 | 2024 | 79 | 0.760 |
Why?
|
| Internet | 5 | 2013 | 472 | 0.750 |
Why?
|
| Survivors | 3 | 2025 | 189 | 0.740 |
Why?
|
| Pilot Projects | 11 | 2026 | 1030 | 0.730 |
Why?
|
| Surveys and Questionnaires | 10 | 2025 | 2790 | 0.730 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2026 | 505 | 0.720 |
Why?
|
| Physicians | 3 | 2017 | 488 | 0.700 |
Why?
|
| Health Promotion | 6 | 2018 | 524 | 0.690 |
Why?
|
| Hypoglycemia | 1 | 2022 | 64 | 0.690 |
Why?
|
| Male | 48 | 2026 | 31410 | 0.680 |
Why?
|
| Aged | 33 | 2026 | 15147 | 0.660 |
Why?
|
| Chicago | 9 | 2024 | 26 | 0.650 |
Why?
|
| Exercise | 7 | 2025 | 970 | 0.640 |
Why?
|
| Self Efficacy | 3 | 2024 | 206 | 0.640 |
Why?
|
| Metformin | 1 | 2021 | 77 | 0.630 |
Why?
|
| Quality of Life | 10 | 2025 | 1266 | 0.620 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2022 | 146 | 0.620 |
Why?
|
| Educational Status | 3 | 2023 | 279 | 0.590 |
Why?
|
| Drug Monitoring | 3 | 2016 | 203 | 0.580 |
Why?
|
| Depression | 6 | 2025 | 910 | 0.530 |
Why?
|
| Cancer Survivors | 3 | 2025 | 131 | 0.530 |
Why?
|
| Programming Languages | 1 | 2017 | 13 | 0.520 |
Why?
|
| Defibrillators | 1 | 2017 | 16 | 0.520 |
Why?
|
| Soccer | 1 | 2017 | 13 | 0.520 |
Why?
|
| Internship and Residency | 2 | 2024 | 800 | 0.510 |
Why?
|
| Transportation Facilities | 1 | 2017 | 1 | 0.510 |
Why?
|
| Architectural Accessibility | 1 | 2017 | 4 | 0.510 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 631 | 0.500 |
Why?
|
| Health Literacy | 3 | 2012 | 95 | 0.500 |
Why?
|
| Research Personnel | 1 | 2017 | 82 | 0.500 |
Why?
|
| Weight Reduction Programs | 2 | 2017 | 63 | 0.500 |
Why?
|
| Geography, Medical | 1 | 2016 | 5 | 0.480 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2016 | 63 | 0.480 |
Why?
|
| Physician-Patient Relations | 4 | 2018 | 430 | 0.480 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 62 | 0.470 |
Why?
|
| Transportation of Patients | 1 | 2017 | 50 | 0.470 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 140 | 0.470 |
Why?
|
| Pharmacies | 1 | 2016 | 36 | 0.470 |
Why?
|
| Multimedia | 3 | 2011 | 9 | 0.470 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2017 | 100 | 0.470 |
Why?
|
| Blood Glucose | 4 | 2023 | 502 | 0.460 |
Why?
|
| Heart Failure | 4 | 2026 | 968 | 0.450 |
Why?
|
| United States | 18 | 2026 | 8189 | 0.430 |
Why?
|
| Young Adult | 8 | 2026 | 4883 | 0.420 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2017 | 770 | 0.420 |
Why?
|
| Health Behavior | 3 | 2024 | 485 | 0.420 |
Why?
|
| Warfarin | 2 | 2012 | 125 | 0.410 |
Why?
|
| Videotape Recording | 2 | 2013 | 46 | 0.410 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 1235 | 0.400 |
Why?
|
| Communication Barriers | 3 | 2018 | 71 | 0.400 |
Why?
|
| Patient Satisfaction | 2 | 2024 | 442 | 0.390 |
Why?
|
| Mass Screening | 2 | 2016 | 700 | 0.390 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2020 | 712 | 0.390 |
Why?
|
| Mobility Limitation | 2 | 2010 | 49 | 0.370 |
Why?
|
| Herb-Drug Interactions | 1 | 2012 | 4 | 0.360 |
Why?
|
| Lycium | 1 | 2012 | 3 | 0.360 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 12 | 0.360 |
Why?
|
| Minority Groups | 2 | 2025 | 143 | 0.350 |
Why?
|
| Adolescent | 8 | 2026 | 6368 | 0.350 |
Why?
|
| Mobile Applications | 3 | 2025 | 142 | 0.340 |
Why?
|
| Overweight | 1 | 2013 | 254 | 0.340 |
Why?
|
| Beverages | 1 | 2012 | 70 | 0.340 |
Why?
|
| Patient-Centered Care | 4 | 2025 | 268 | 0.330 |
Why?
|
| Glycemic Index | 1 | 2011 | 23 | 0.330 |
Why?
|
| Health Services Accessibility | 3 | 2026 | 603 | 0.310 |
Why?
|
| Women's Health | 2 | 2010 | 376 | 0.300 |
Why?
|
| Insurance, Health | 1 | 2011 | 153 | 0.300 |
Why?
|
| Patient Compliance | 3 | 2015 | 370 | 0.300 |
Why?
|
| Sleep | 3 | 2023 | 246 | 0.300 |
Why?
|
| Diabetic Retinopathy | 2 | 2020 | 60 | 0.290 |
Why?
|
| Poverty | 3 | 2017 | 307 | 0.290 |
Why?
|
| Cell Phone | 1 | 2009 | 42 | 0.280 |
Why?
|
| Medicaid | 1 | 2013 | 379 | 0.280 |
Why?
|
| Time Factors | 6 | 2026 | 3779 | 0.280 |
Why?
|
| Cluster Analysis | 2 | 2026 | 267 | 0.270 |
Why?
|
| Primary Health Care | 7 | 2024 | 726 | 0.270 |
Why?
|
| HIV Infections | 2 | 2026 | 961 | 0.260 |
Why?
|
| Social Support | 4 | 2013 | 394 | 0.260 |
Why?
|
| Chronic Disease | 3 | 2025 | 745 | 0.260 |
Why?
|
| Algorithms | 4 | 2006 | 1060 | 0.240 |
Why?
|
| Hospitalization | 3 | 2024 | 1404 | 0.230 |
Why?
|
| Efficiency, Organizational | 1 | 2026 | 98 | 0.230 |
Why?
|
| Retrospective Studies | 4 | 2026 | 6957 | 0.220 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 163 | 0.220 |
Why?
|
| Fitness Trackers | 1 | 2025 | 20 | 0.220 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 97 | 0.220 |
Why?
|
| Technology | 2 | 2021 | 53 | 0.220 |
Why?
|
| Computed Tomography Angiography | 1 | 2026 | 143 | 0.220 |
Why?
|
| Neoplasms | 2 | 2025 | 1378 | 0.220 |
Why?
|
| Computer-Assisted Instruction | 1 | 2005 | 80 | 0.210 |
Why?
|
| Psychometrics | 4 | 2025 | 396 | 0.210 |
Why?
|
| Public Health Informatics | 1 | 2004 | 9 | 0.210 |
Why?
|
| Blood Pressure | 4 | 2021 | 537 | 0.210 |
Why?
|
| Electronic Health Records | 2 | 2025 | 398 | 0.210 |
Why?
|
| Research | 2 | 2006 | 195 | 0.210 |
Why?
|
| Access to Information | 1 | 2004 | 31 | 0.210 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1569 | 0.200 |
Why?
|
| Program Evaluation | 1 | 2026 | 501 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2026 | 224 | 0.200 |
Why?
|
| Influenza, Human | 1 | 2026 | 213 | 0.200 |
Why?
|
| Melatonin | 2 | 2020 | 66 | 0.200 |
Why?
|
| Qualitative Research | 3 | 2024 | 763 | 0.200 |
Why?
|
| Pulmonary Embolism | 1 | 2026 | 198 | 0.200 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 79 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2026 | 332 | 0.200 |
Why?
|
| Logistic Models | 5 | 2016 | 1274 | 0.190 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 932 | 0.190 |
Why?
|
| Telephone | 4 | 2022 | 123 | 0.180 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 62 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 129 | 0.180 |
Why?
|
| Pregnancy | 2 | 2021 | 2401 | 0.170 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 95 | 0.170 |
Why?
|
| Drug Utilization | 2 | 2020 | 204 | 0.170 |
Why?
|
| Models, Neurological | 2 | 1993 | 83 | 0.170 |
Why?
|
| Vascular Stiffness | 1 | 2021 | 17 | 0.170 |
Why?
|
| Pennsylvania | 1 | 2021 | 66 | 0.160 |
Why?
|
| Self-Control | 1 | 2020 | 10 | 0.160 |
Why?
|
| Actigraphy | 1 | 2021 | 51 | 0.160 |
Why?
|
| Cooperative Behavior | 3 | 2015 | 230 | 0.160 |
Why?
|
| Adie Syndrome | 1 | 2020 | 1 | 0.160 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2020 | 5 | 0.160 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 34 | 0.150 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 15 | 0.150 |
Why?
|
| Drugs, Generic | 1 | 2020 | 20 | 0.150 |
Why?
|
| Pharmacy | 1 | 2020 | 17 | 0.150 |
Why?
|
| Physicians, Women | 1 | 2020 | 42 | 0.150 |
Why?
|
| Nutrition Surveys | 2 | 2019 | 149 | 0.150 |
Why?
|
| Atherosclerosis | 1 | 2021 | 162 | 0.150 |
Why?
|
| Circadian Clocks | 1 | 2020 | 46 | 0.150 |
Why?
|
| Statistics as Topic | 2 | 2017 | 147 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2026 | 758 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2020 | 5834 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 2 | 2026 | 318 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2025 | 901 | 0.130 |
Why?
|
| Culture | 2 | 2012 | 82 | 0.130 |
Why?
|
| Pharmaceutical Services | 1 | 2017 | 33 | 0.130 |
Why?
|
| Age Factors | 3 | 2012 | 1595 | 0.130 |
Why?
|
| Cross-Sectional Studies | 5 | 2020 | 2739 | 0.130 |
Why?
|
| Software | 2 | 2009 | 401 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 5682 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 178 | 0.130 |
Why?
|
| Patient Care Planning | 1 | 2017 | 85 | 0.130 |
Why?
|
| Perception | 2 | 2015 | 187 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2026 | 811 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 78 | 0.120 |
Why?
|
| Pneumonia | 3 | 2005 | 295 | 0.120 |
Why?
|
| Data Collection | 3 | 2022 | 384 | 0.120 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 183 | 0.120 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 634 | 0.120 |
Why?
|
| Veterans Health | 1 | 2017 | 147 | 0.120 |
Why?
|
| Smartphone | 1 | 2017 | 75 | 0.120 |
Why?
|
| Risk Factors | 5 | 2020 | 5475 | 0.120 |
Why?
|
| Community-Acquired Infections | 4 | 2005 | 95 | 0.110 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 806 | 0.110 |
Why?
|
| Random Allocation | 1 | 2015 | 200 | 0.110 |
Why?
|
| Medical Errors | 1 | 2017 | 202 | 0.110 |
Why?
|
| ROC Curve | 3 | 2012 | 295 | 0.110 |
Why?
|
| Behavior Therapy | 2 | 2020 | 169 | 0.110 |
Why?
|
| Reminder Systems | 2 | 2022 | 75 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2017 | 312 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 309 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2012 | 606 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 757 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 2500 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2018 | 535 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2022 | 3340 | 0.100 |
Why?
|
| Transportation | 1 | 2013 | 33 | 0.100 |
Why?
|
| Professional-Patient Relations | 2 | 2015 | 128 | 0.100 |
Why?
|
| Illinois | 1 | 2013 | 13 | 0.100 |
Why?
|
| Child, Preschool | 2 | 2017 | 2090 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 888 | 0.090 |
Why?
|
| Synapses | 2 | 1993 | 195 | 0.090 |
Why?
|
| Drug Utilization Review | 1 | 2013 | 50 | 0.090 |
Why?
|
| Potassium | 1 | 1993 | 98 | 0.090 |
Why?
|
| Child | 3 | 2021 | 4653 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2015 | 338 | 0.090 |
Why?
|
| International Normalized Ratio | 1 | 2012 | 36 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 170 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 1993 | 190 | 0.080 |
Why?
|
| Acculturation | 1 | 2011 | 38 | 0.080 |
Why?
|
| User-Computer Interface | 2 | 2009 | 127 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2012 | 94 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 347 | 0.080 |
Why?
|
| Incidence | 2 | 2025 | 1433 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 1993 | 284 | 0.080 |
Why?
|
| Narration | 1 | 2011 | 54 | 0.080 |
Why?
|
| Patient Care | 1 | 2011 | 79 | 0.080 |
Why?
|
| Comorbidity | 2 | 2025 | 1122 | 0.080 |
Why?
|
| Smoking Prevention | 1 | 2011 | 163 | 0.080 |
Why?
|
| Peripheral Arterial Disease | 1 | 2012 | 165 | 0.080 |
Why?
|
| Affect | 2 | 2021 | 132 | 0.080 |
Why?
|
| Walking | 1 | 2012 | 248 | 0.080 |
Why?
|
| Diet | 1 | 2013 | 540 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2011 | 147 | 0.080 |
Why?
|
| Nerve Net | 1 | 1991 | 105 | 0.080 |
Why?
|
| Anxiety | 2 | 2023 | 427 | 0.070 |
Why?
|
| Research Design | 1 | 2012 | 589 | 0.070 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 10 | 0.070 |
Why?
|
| Diet, Fat-Restricted | 1 | 2009 | 34 | 0.070 |
Why?
|
| Vitamin D | 1 | 2010 | 139 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1294 | 0.070 |
Why?
|
| Disease Progression | 3 | 2020 | 1229 | 0.070 |
Why?
|
| Self Report | 2 | 2025 | 395 | 0.070 |
Why?
|
| Forecasting | 2 | 2006 | 231 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2011 | 529 | 0.060 |
Why?
|
| Self-Help Groups | 1 | 2007 | 37 | 0.060 |
Why?
|
| Zambia | 1 | 2026 | 19 | 0.060 |
Why?
|
| Nebraska | 1 | 2006 | 6 | 0.060 |
Why?
|
| Game Theory | 1 | 2006 | 4 | 0.060 |
Why?
|
| Linear Models | 2 | 2010 | 405 | 0.060 |
Why?
|
| Altruism | 1 | 2006 | 14 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 447 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2026 | 65 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2011 | 553 | 0.060 |
Why?
|
| Computer Literacy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Medicare | 1 | 2010 | 629 | 0.060 |
Why?
|
| Health Resources | 1 | 2026 | 92 | 0.060 |
Why?
|
| Crossing Over, Genetic | 1 | 2005 | 4 | 0.060 |
Why?
|
| Computers | 1 | 2005 | 49 | 0.050 |
Why?
|
| Focus Groups | 2 | 2017 | 329 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 137 | 0.050 |
Why?
|
| Motivation | 1 | 2006 | 298 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 18 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 2025 | 146 | 0.050 |
Why?
|
| Rest | 1 | 2023 | 51 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2006 | 347 | 0.050 |
Why?
|
| Safe Sex | 1 | 2022 | 25 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2004 | 220 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 439 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 92 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2002 | 12 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2002 | 65 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2003 | 91 | 0.040 |
Why?
|
| Translating | 1 | 2002 | 21 | 0.040 |
Why?
|
| Biomedical Technology | 1 | 2021 | 6 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 201 | 0.040 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2001 | 12 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2021 | 10 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 1454 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2021 | 64 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 1719 | 0.040 |
Why?
|
| Machine Learning | 1 | 2022 | 197 | 0.040 |
Why?
|
| Medical Informatics | 1 | 2001 | 72 | 0.040 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 2 | 0.040 |
Why?
|
| Medication Therapy Management | 1 | 2020 | 18 | 0.040 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2020 | 11 | 0.040 |
Why?
|
| Hypertension | 1 | 2025 | 618 | 0.040 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2020 | 17 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2020 | 40 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 737 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2023 | 364 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 48 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 39 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2003 | 216 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 180 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 378 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2020 | 192 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2018 | 58 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 244 | 0.030 |
Why?
|
| Communication | 2 | 2015 | 608 | 0.030 |
Why?
|
| Health Status | 1 | 2021 | 448 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 122 | 0.030 |
Why?
|
| Trust | 1 | 2018 | 82 | 0.030 |
Why?
|
| Leadership | 1 | 2020 | 214 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1148 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2006 | 488 | 0.030 |
Why?
|
| Language | 1 | 2018 | 155 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2018 | 197 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 554 | 0.030 |
Why?
|
| Community Pharmacy Services | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2194 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2017 | 535 | 0.030 |
Why?
|
| Professional Role | 1 | 2015 | 45 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 106 | 0.030 |
Why?
|
| Brain | 1 | 2023 | 1672 | 0.030 |
Why?
|
| Air Pressure | 1 | 1994 | 4 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1994 | 56 | 0.030 |
Why?
|
| Psychology | 1 | 2013 | 45 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 549 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2005 | 2651 | 0.020 |
Why?
|
| Cybernetics | 1 | 1993 | 1 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2013 | 60 | 0.020 |
Why?
|
| Membranes | 1 | 1993 | 18 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 142 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 2116 | 0.020 |
Why?
|
| Time | 1 | 2012 | 30 | 0.020 |
Why?
|
| Action Potentials | 1 | 1993 | 113 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 1993 | 134 | 0.020 |
Why?
|
| Aorta | 1 | 1993 | 108 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2012 | 85 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2013 | 230 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 213 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1993 | 253 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2011 | 74 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 1993 | 267 | 0.020 |
Why?
|
| Gait | 1 | 2012 | 124 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 1991 | 44 | 0.020 |
Why?
|
| Exercise Test | 1 | 2012 | 257 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2011 | 138 | 0.020 |
Why?
|
| Ion Channels | 1 | 1991 | 92 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2004 | 1117 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 1172 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 63 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 274 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2011 | 287 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 225 | 0.020 |
Why?
|
| Lung | 1 | 1994 | 969 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2006 | 57 | 0.010 |
Why?
|
| Animals | 3 | 1994 | 21493 | 0.010 |
Why?
|
| Workload | 1 | 2006 | 132 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 198 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 430 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2004 | 1439 | 0.010 |
Why?
|
| Infant | 1 | 2004 | 1718 | 0.010 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1994 | 4 | 0.010 |
Why?
|
| Tantalum | 1 | 1994 | 5 | 0.010 |
Why?
|
| Surface Tension | 1 | 1994 | 19 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 491 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1994 | 626 | 0.010 |
Why?
|
| Radiography | 1 | 1994 | 559 | 0.010 |
Why?
|
| Rats | 1 | 1994 | 2005 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1994 | 715 | 0.000 |
Why?
|
| Models, Biological | 1 | 1994 | 1193 | 0.000 |
Why?
|